StockData
Genenta Science S.p.A. logo

Genenta Science S.p.A. (SAEN) income statement

SAENNasdaqBiological Products, (No Diagnostic Substances)
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Apr 1, 2026Score 6/30
$0.58+0.00 (+0.85%)

Close on Nov 18, 2026Market cap $13.64MP/E –Yield –

See a number that looks wrong?